314 related articles for article (PubMed ID: 28874937)
21. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP).
Deshpande A; Walker R; Schulte R; Pallotta AM; Tereshchenko LG; Hu B; Kadri SS; Klompas M; Rothberg MB
Trials; 2023 Sep; 24(1):595. PubMed ID: 37716990
[TBL] [Abstract][Full Text] [Related]
22. Empiric management of community-acquired pneumonia in Australian emergency departments.
Maxwell DJ; McIntosh KA; Pulver LK; Easton KL
Med J Aust; 2005 Nov; 183(10):520-4. PubMed ID: 16296965
[TBL] [Abstract][Full Text] [Related]
23. Improved management of community-acquired pneumonia in the emergency department.
Julián-Jiménez A; Palomo de los Reyes MJ; Parejo Miguez R; Laín-Terés N; Cuena-Boy R; Lozano-Ancín A
Arch Bronconeumol; 2013 Jun; 49(6):230-40. PubMed ID: 23477946
[TBL] [Abstract][Full Text] [Related]
24. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.
Polverino E; Torres A; Menendez R; Cillóniz C; Valles JM; Capelastegui A; Marcos MA; Alfageme I; Zalacain R; Almirall J; Molinos L; Bello S; Rodríguez F; Blanquer J; Dorado A; Llevat N; Rello J;
Thorax; 2013 Nov; 68(11):1007-14. PubMed ID: 24130227
[TBL] [Abstract][Full Text] [Related]
25. Pharmacist addition to the post-ED visit review of discharge antimicrobial regimens.
Miller K; McGraw MA; Tomsey A; Hegde GG; Shang J; O'Neill JM; Venkat A
Am J Emerg Med; 2014 Oct; 32(10):1270-4. PubMed ID: 25171797
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based guidelines for evaluation and antimicrobial therapy for common emergency department infections.
Nassisi D; Oishi ML
Emerg Med Pract; 2012 Jan; 14(1):1-28; quiz 28-9. PubMed ID: 22292348
[TBL] [Abstract][Full Text] [Related]
27. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
[TBL] [Abstract][Full Text] [Related]
28. Time to oral anticoagulant reversal in intracranial hemorrhage with an emergency medicine pharmacist presence.
Hutcheson B; Spetz S; Davenport J; Shuler E
Am J Emerg Med; 2024 Jun; 80():114-118. PubMed ID: 38547626
[TBL] [Abstract][Full Text] [Related]
29. Health care-associated pneumonia in haemodialysis patients: clinical outcomes in patients treated with narrow versus broad spectrum antibiotic therapy.
Taylor SP; Taylor BT
Respirology; 2013 Feb; 18(2):364-8. PubMed ID: 23066809
[TBL] [Abstract][Full Text] [Related]
30. Impact of prospective verification of intravenous antibiotics in an ED.
Hunt A; Nakajima S; Hall Zimmerman L; Patel M
Am J Emerg Med; 2016 Dec; 34(12):2392-2396. PubMed ID: 27641249
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan area of Japan.
Sugisaki M; Enomoto T; Shibuya Y; Matsumoto A; Saitoh H; Shingu A; Narato R; Nomura K
J Infect Chemother; 2012 Jun; 18(3):352-60. PubMed ID: 22116463
[TBL] [Abstract][Full Text] [Related]
32. New directions in antiinfective therapy for community-acquired pneumonia in the emergency department.
Moran GJ
Pharmacotherapy; 2001 Jul; 21(7 Pt 2):95S-99S. PubMed ID: 11446525
[TBL] [Abstract][Full Text] [Related]
33. Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumonia.
McEvoy C; Micek ST; Reichley RM; Kan J; Hoban A; Hoffmann J; Shorr AF; Kollef MH
Surg Infect (Larchmt); 2014 Jun; 15(3):283-9. PubMed ID: 24801126
[TBL] [Abstract][Full Text] [Related]
34. Healthcare-associated pneumonia in the emergency department.
Slaven EM; Santanilla JI; DeBlieux PM
Semin Respir Crit Care Med; 2009 Feb; 30(1):46-51. PubMed ID: 19199186
[TBL] [Abstract][Full Text] [Related]
35. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.
Lancaster JW; Lawrence KR; Fong JJ; Doron SI; Garpestad E; Nasraway SA; Devlin JW
Pharmacotherapy; 2008 Jul; 28(7):852-62. PubMed ID: 18576900
[TBL] [Abstract][Full Text] [Related]
36. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
Mortensen EM; Restrepo MI; Anzueto A; Pugh J
Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
[TBL] [Abstract][Full Text] [Related]
37. Septic shock and adequacy of early empiric antibiotics in the emergency department.
Flaherty SK; Weber RL; Chase M; Dugas AF; Graver AM; Salciccioli JD; Cocchi MN; Donnino MW
J Emerg Med; 2014 Nov; 47(5):601-7. PubMed ID: 25218723
[TBL] [Abstract][Full Text] [Related]
38. Community-acquired pneumonia with risk for drug-resistant pathogens.
Fleming V; Buck B; Nix N; Kumar P; Southwood R
South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
[TBL] [Abstract][Full Text] [Related]
39. Emergency department management of childhood pneumonia in the United States prior to publication of national guidelines.
Neuman MI; Shah SS; Shapiro DJ; Hersh AL
Acad Emerg Med; 2013 Mar; 20(3):240-6. PubMed ID: 23517255
[TBL] [Abstract][Full Text] [Related]
40. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia.
Brito V; Niederman MS
Curr Opin Infect Dis; 2009 Jun; 22(3):316-25. PubMed ID: 19352176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
